Anil Tarachandani set to share experience with collecting Actigraphy data to measure mobility and activity in ALS participants in VRG50635-002 clinical study at the Actigraph Digital Data Summi

Verge Genomics is proud to announce that our VP, Head of Translational Medicine, Anil Tarachandani, will be discussing Verge Genomics experience with collecting Actigraphy data to measure mobility and activity in ALS participants in VRG50635-002 clinical study at the Actigraph Digital Data Summit next week.